CERE - Cerevel Therapeutics gains on report Tempur Sealy will be the subject of FTC meeting
2024-06-27 13:40:30 ET
More on Cerevel Therapeutics
- Cerevel Therapeutics: Time For A Risk Arbitrage Play?
- Cerevel Therapeutics sinks amid some worry on FTC review of AbbVie deal
- Cerevel Therapeutics seesaws amid FTC notice on closed door meeting
- Seeking Alpha’s Quant Rating on Cerevel Therapeutics
- Historical earnings data for Cerevel Therapeutics